ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1882

Vessels Under Fire: National Mortality Trends in Systemic Vasculitides in the United States, 1999–2020

Aziz-ur-Rahman Khalid1, Ghassan Makhoul2, Hasan Munshi2, Islam Rajab2, Emmanuel Olumuyide3, MD Walid Akram Hussain2, Ahmed Huzien2 and Robert Lahita4, 1St. Joseph's University Medical Center, wayne, 2St. Josephs University Medical Center, Paterson, 3Advocate Illinois Masonic Medical Center, Chicago, 4St. Josephs University Medical Center, Wayne, NJ

Meeting: ACR Convergence 2025

Keywords: Disparities, Epidemiology, Mortality, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1877–1913) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic vasculitides are rare but potentially life-threatening inflammatory disorders affecting blood vessels. Despite therapeutic advances, national mortality trends across vasculitis subtypes remain poorly defined. We analyzed U.S. mortality trends from 1999–2020 using CDC WONDER, focusing on 10 vasculitis-related ICD-10 codes.

Methods: CDC WONDER Multiple Cause of Death data (1999–2020) were queried using ICD-10 codes: D69.0 (Allergic purpura), M30.0 (Polyarteritis nodosa), M30.1 (Churg-Strauss), M30.3 (Kawasaki disease), M31.3 (Wegener granulomatosis), M31.4 (Takayasu arteritis), M31.5 (Giant cell arteritis with polymyalgia rheumatica), M31.6 (Other giant cell arteritis), M31.7 (Microscopic polyangiitis), and M35.2 (Behçet disease). Age-adjusted mortality rates (AAMRs) were calculated using the 2000 U.S. standard population. Analyses were stratified by age, sex, race/ethnicity, urbanization, state, and place of death.

Results: A total of 11,602 vasculitis-related deaths occurred from 1999–2020. The overall AAMR was 0.15 per 100,000, declining from 0.20 in 1999 to 0.09 in 2020. The highest age-specific mortality occurred in adults ≥85 years (AAMR: 1.69), with the lowest in children 5–14 years (AAMR: 0.004). Females accounted for 56% of deaths, with AAMRs nearly equal between sexes (0.149 vs. 0.147). By race, American Indian/Alaska Native (0.165) and White (0.161) individuals had the highest AAMRs, while Black (0.068) and Asian/Pacific Islander (0.070) individuals had the lowest. Hispanic individuals had an AAMR of 0.117. The highest mortality occurred in micropolitan (0.205) and noncore rural areas (0.178). Regarding place of death, 54.3% occurred in inpatient medical facilities, followed by 20.0% at home and 13.3% in nursing homes.

Conclusion: Vasculitis-related mortality in the U.S. has declined substantially since 1999. However, disparities persist among older adults, rural populations, and American Indian/Alaska Native individuals. These findings highlight the need for improved access to rheumatologic care and early detection strategies in high-risk populations.

Supporting image 1Graphs showing state, urbanization, gender, race, age, and year mortality from Vasculitis


Disclosures: A. Khalid: None; G. Makhoul: None; H. Munshi: None; I. Rajab: None; E. Olumuyide: None; M. Hussain: None; A. Huzien: None; R. Lahita: None.

To cite this abstract in AMA style:

Khalid A, Makhoul G, Munshi H, Rajab I, Olumuyide E, Hussain M, Huzien A, Lahita R. Vessels Under Fire: National Mortality Trends in Systemic Vasculitides in the United States, 1999–2020 [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/vessels-under-fire-national-mortality-trends-in-systemic-vasculitides-in-the-united-states-1999-2020/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vessels-under-fire-national-mortality-trends-in-systemic-vasculitides-in-the-united-states-1999-2020/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology